ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Q2 FY27 revenue ₹83.1 Cr (+17%), PAT ₹4.86 Cr (+26%), EBITDA margin 21.6%. The FY27 ₹420–430 Cr target needs a steep H2 ramp the Q2 run-rate doesn't support.
Q2FY27 revenue ₹83.1 Cr (+17.3% YoY), EBITDA ₹17.95 Cr (21.6% margin), PAT ₹4.86 Cr. H1 revenue ₹151.9 Cr, PAT ₹8.2 Cr. SteriPort Line 3 commissioned September 2026.
Amanta Healthcare delivers solid FY26 results with significant profit growth, transitioning toward high-margin specialized products like Steriport and ophthalmic solutions.
Amanta reported Q1FY27 revenue of INR 69 Cr (5% YoY) with 21% EBITDA margins. Strategy focuses on high-margin SteriPort/SVP capacity expansion and cost optimization via solar power.
Amanta reported FY26 revenue of ₹288cr with 22% EBITDA margins. Strategy focuses on high-margin SteriPort capacity expansion and renewable energy cost savings.
Amanta Healthcare reported FY26 revenue of ₹288 Cr (+5% YoY) and PAT of ₹15 Cr (+42% YoY), driven by improved margins and reduced finance costs.